Asfotase Alfa
ATC A16AB13 · 8 markets · 28 records
Asfotase Alfa
Forms
AU 6 records · 3 strengths
- 100 mg/mLinjectionSTRENSIQ asfotase alfa rch 80 mg/0.80 mL injection solution vial
- 40 mg/mLinjectionSTRENSIQ asfotase alfa rch 40 mg/1.00 ml solution for injection vial
Records without a stated strength · 1 STRENSIQ
CA 5 records · 2 strengths
US 4 records · 4 strengths
GB 4 records · 4 strengths
- 80 mg/0.8 mLinjectionStrensiq 18mg/0.45ml solution for injection vials
- 40 mg/1 mLinjectionStrensiq 18mg/0.45ml solution for injection vials
- 28 mg/0.7 mLinjectionStrensiq 18mg/0.45ml solution for injection vials
- 18 mg/0.45 mLinjectionStrensiq 18mg/0.45ml solution for injection vials
HK 4 records · 1 strengths
Records without a stated strength · 1 STRENSIQ SOLUTION FOR INJECTION 18MG/0.45ML
SG 2 records · 2 strengths
- 100 mg/mLinjectionSTRENSIQ SOLUTION FOR INJECTION 40 MG/ML
- 40 mg/mLinjectionSTRENSIQ SOLUTION FOR INJECTION 40 MG/ML
TW 2 records · 2 strengths
- 100 mginjectionSTRENSIQ 40 mg/ml solution for subcutaneous賜壯骼皮下注射劑100毫克/毫升
- 40 mginjectionSTRENSIQ 40 mg/ml solution for subcutaneous賜壯骼皮下注射劑40毫克/毫升
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 STRENSIQ
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.